Integrated Nanotherapeutics is founded by a world-class team of scientists with multidisciplinary expertise in preclinical research, drug development, and therapeutic commercialization. Collectively, our founders and scientists bring more than 100 years of experience in lipid nanoparticle science and drug development. Our team has contributed to five approved LNP drugs to date: Abelcet®, Myocet®, Marqibo®, Onpattro®, and Comirnaty®